, Volume 16, Issue 3, pp 141–150 | Cite as

Diabetes and atherosclerosis — The role of insulin

  • R. W. Stout
Review Articles


Public Health Atherosclerosis Internal Medicine Human Physiology Metabolic Disease 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Strandness, D. W., Priest, R. W., Gibbons, G. E.: Combined clinical and pathologic study of diabetic and nondiabetic peripheral arterial disease. Diabetes13, 336–372 (1964)Google Scholar
  2. 2.
    Epstein, F. H.: Hyperglycemia. A risk factor in coronary heart disease. Circulation36, 609–619 (1967)PubMedGoogle Scholar
  3. 3.
    Mainland, D.: The risk of fallacious conclusions from autopsy data on the incidence of disease with applications to heart disease. Am. Heart J.45, 644–654 (1953)PubMedGoogle Scholar
  4. 4.
    Garcia, M. J., McNamara, P. M., Gordon, T., Kannel, W. B.: Morbidity and mortality in diabetics in the Framingham population. Sixteen year follow-up study. Diabetes23, 105–111 (1974)PubMedGoogle Scholar
  5. 5.
    Gordon, T., Castelli, W. P., Hjortland, M. C., Kannel, W. B., Dawber, T. R.: Diabetes, blood lipids, and the role of obesity in coronary heart disease risk for women. The Framingham Study. Ann. Intern. Med.87, 393–397 (1977)PubMedGoogle Scholar
  6. 6.
    Keen, H., Jarrett, R. J.: Macroangiopathy — its prevalence in asymptomatic diabetes. Adv. Metab. Disord. [Suppl.]2, 3–9 (1973)Google Scholar
  7. 7.
    Ostrander, L. D., Francis, T., Hayner, N. S., Kjelsberg, M. O., Epstein, F. H.: The relationship of cardio-vascular disease to hyperglycemia. Ann. Intern. Med.62, 1188–1198 (1965)PubMedGoogle Scholar
  8. 8.
    Epstein, F. H., Ostrander, L. D., Johnson, B. J., Payne, M. W., Hayner, N. S., Keller, J. B., Francis, T.: Epidemiological studies of cardiovascular disease in a total community -Tecumseh, Michigan. Ann. Intern. Med.62, 1170–1187 (1965)PubMedGoogle Scholar
  9. 9.
    Pell, S., D'Alonzo, C. A.: Factors associated with long-term survival of diabetes. J. A. M. A.214, 1833–1840 (1970)PubMedGoogle Scholar
  10. 10.
    Wahlberg, F., Thomasson, B.: Glucose tolerance in ischaemic cardiovascular disease. In: Carbohydrate metabolism and its disorders. Dickens, F., Randle, P. J., Whelen, W. J. (Eds.); pp. 185–198. London: Academic Press 1968Google Scholar
  11. 11.
    Heinle, R. A., Levy, R. I., Frederickson, D. S., Gorlin, R.: Lipid and carbohydrate abnormalities in patients with angiographically documented coronary artery disease. Am. J. Cardiol.24, 178–186 (1969)PubMedGoogle Scholar
  12. 12.
    Falsetti, H. L., Schnatz, J. D., Greene, D. G., Bunnell, I. L.: Serum lipids and glucose tolerance in angiographically proved coronary artery disease. Chest58, 111–115 (1970)PubMedGoogle Scholar
  13. 13.
    Kingsbury, K. J.: The relation between glucose tolerance and atherosclerotic vascular disease. Lancet1966 II, 1374–1379Google Scholar
  14. 14.
    Sloan, J. M., Mackay, J. S., Sheridan, B.: Glucose tolerance and insulin response in atherosclerosis. Br. Med. J.1970 IV, 586–588Google Scholar
  15. 15.
    Ingelfinger, J. A., Bennet, P. H., Liebow, I. M., Miller, M.: Coronary heart disease in the Pima Indians. Electrocardiographic findings and postmortem evidence of myocardial infarction in a population with a high prevalence of diabetes mellitus. Diabetes25, 561–565 (1976)PubMedGoogle Scholar
  16. 16.
    Merimee, T. J.: A follow-up study of vascular disease in growth-hormone-deficient dwarfs with diabetes. N. Engl. J. Med.298, 1217–1222 (1978)PubMedGoogle Scholar
  17. 17.
    Stout, R. W., Bierman, E. L., Brunzell, J. D.: Atherosclerosis and disorders of lipid metabolism in diabetes. In: Physiological and biochemical basis of diabetes. Vallence-Owen, J. (Ed.), pp. 125–170. Lancaster: M. T. P. 1975Google Scholar
  18. 18.
    Stearns, S., Schlesinger, M. J., Rudy, A.: Incidence and clinical significance of coronary artery disease in diabetes mellitus. Arch. Intern. Med.80, 463–474 (1947)Google Scholar
  19. 19.
    Ricketts, H. T.: The problem of degenerative vascular disease in diabetes. Am. J. Med.19, 933–945 (1955)PubMedGoogle Scholar
  20. 20.
    Bradley, R. F., Bryfogle, J. W.: Survival of diabetic patients after myocardial infarction. Am. J. Med.20, 207–216 (1956)PubMedGoogle Scholar
  21. 21.
    Breithaupt, D. J., Leckie, R. B.: Diabetes mellitus: a study of the practicability of life insurance. Can. Med. Assoc. J.85, 299–302 (1961)Google Scholar
  22. 22.
    Liebow, I. M., Hellerstein, H. K., Miller, M.: Arteriosclerotic heart disease in diabetes mellitus. Am. J. Med.18, 438–447 (1955)PubMedGoogle Scholar
  23. 23.
    Downie, E., Martin, F. I. R.: Vascular disease in juvenile diabetic patients of long duration. Diabetes8, 383–387 (1959)PubMedGoogle Scholar
  24. 24.
    New, M. I., Roberts, T. N., Bierman, E. L., Reader, G. G.: The significance of blood lipid alterations in diabetes mellitus. Diabetes12, 208–212 (1963)PubMedGoogle Scholar
  25. 25.
    Reinheimer, W., Bliffen, G., McCoy, J., Wallace, D., Albrink, M. J.: Weight gain, serum lipids and vascular disease in diabetes. Am. J. Clin. Nutr.20, 986–996 (1967)PubMedGoogle Scholar
  26. 26.
    Pyke, D. A.: Coronary disease and diabetes. Postgrad. Med. J.44, 966–968 (1968)Google Scholar
  27. 27.
    University Group Diabetes Program: A study of the effects of hypoglycemic agents on the vascular complications of patients with adult-onset diabetes. Diabetes19 [Suppl. 2], 747–830 (1970)Google Scholar
  28. 28.
    Porte, D., Jr., Bagdade, J.: Human insulin secretion: an integrated approach. Annu. Rev. Med.21, 219–240 (1970)PubMedGoogle Scholar
  29. 29.
    Bagdade, J. D., Bierman, E. L., Porte, D. Jr.: The significance of basal insulin levels in evaluation of the insulin response to glucose in diabetic and non-diabetic subjects. J. Clin. Invest.46, 1549–1557 (1967)PubMedGoogle Scholar
  30. 30.
    Pyke, D. A., Please, N. W.: Obesity, parity and diabetes. J. Endocrinol.15, 26–33 (1957)Google Scholar
  31. 31.
    Goodner, C. J., Porte, D. Jr.: Determinants of basal insulin secretion in man. In: Handbook of physiology, Section 7, Part 1, pp. 597–609. Washington DC: American Physiological Society 1972Google Scholar
  32. 32.
    Grodsky, G. M.: Production of autoantibodies to insulin in man and rabbits. Diabetes14, 396–403 (1965)PubMedGoogle Scholar
  33. 33.
    Pearson, M. J., Martin, F. I. R.: The separation of total plasma insulin from binding proteins using gel filtration: its application to the measurement of rate of insulin disappearance. Diabetologia6, 581–585 (1970)PubMedGoogle Scholar
  34. 34.
    Heding, L. G.: Determination of total serum insulin (IRI) in insulin-treated diabetic patients. Diabetologia8, 260–266 (1972)PubMedGoogle Scholar
  35. 35.
    Gennaro, W. D., Van Norman, J. D.: Quantitation of free, total, and antibody-bound insulin in insulin-treated diabetics. Clin. Chem.21, 873–879 (1975)PubMedGoogle Scholar
  36. 36.
    Nakagawa, S., Nakayama, H., Sasaki, T., Yoshino, K., Yu, Y. Y., Shinozaki, K., Aoki, S., Mashimo, K.: A simple method for the determination of serum free insulin levels in insulin-treated patients. Diabetes22, 590–600 (1973)PubMedGoogle Scholar
  37. 37.
    Danowski, T. S., Lombardo, Y. B., Mendelsohn, L. V., Corredor, D. G., Morgan, C. R., Sabeh, G.: Insulin patterns prior to and after onset of diabetes. Metabolism18, 731–740 (1969)PubMedGoogle Scholar
  38. 38.
    Jackson, W. P. U., van Mieghem, W., Keller, P.: Insulin excess as the initial lesion in diabetes. Lancet1972 I, 1040–1043Google Scholar
  39. 39.
    Reaven, G. M., Olefsky, J., Farquhar, J. W.: Does hyperglycaemia or hyperinsulinaemia characterise the patient with chemical diabetes. Lancet1972 I, 1247–1249Google Scholar
  40. 40.
    Savage, P. J., Dippe, S. E., Bennett, P. H., Gordon, P., Roth, J., Rushforth, N. B., Miller, M.: Hyperinsulinemia and hypoinsulinemia. Insulin responses to oral carbohydrate over a wide spectrum of glucose tolerance. Diabetes24, 363–368 (1975)Google Scholar
  41. 41.
    Ostrander, L. D., Neff, B. J., Block, W. D., Francis, T., Epstein, F. H.: Hyperglycemia and hypertriglyceridemia among persons with coronary heart disease. Ann. Intern. Med.67, 34–41 (1967)PubMedGoogle Scholar
  42. 42.
    Santen, R. J., Willis, P. W., Fajans, S.S.: Atherosclerosis in diabetes mellitus. Arch. Intern. Med.130, 833–843 (1972)PubMedGoogle Scholar
  43. 43.
    Carlson, L. A., Bottiger, L. E.: Ischaemic heart disease in relation to fasting values of plasma triglycerides and cholesterol. Lancet1972 I, 865–868Google Scholar
  44. 44.
    Bierman, E. L., Porte, D. Jr., Bagdade, J. D.: Hypertriglyceridemia and glucose intolerance in man. In: Adipose tissue. Jeanrenaud, B., Hepp, D. (Eds.), pp. 209–212. New York: Academic Press 1970Google Scholar
  45. 45.
    Topping, D. L., Mayes, P. A.: The immediate effects of insulin and fructose on the metabolism of the perfused liver: changes in lipoprotein secretion, fatty acid oxidation and esterification, lipogenesis and carbohydrate metabolism. Biochem. J.126, 295–311 (1972)Google Scholar
  46. 46.
    Robertson, R. P., Gavareski, D. J., Henderson, J. D., Porte, D., Jr., Bierman, E. L.: Accelerated triglyceride secretion. A metabolic consequence of obesity. J. Clin. Invest.52, 1620–1626 (1973)PubMedGoogle Scholar
  47. 47.
    Kashyap, L., Magill, F., Rojas, L., Hoffman, M. M.: Insulin and non-esterified fatty acid metabolism in asymptomatic diabetics and atherosclerotic subjects. Can. Med. Assoc. J.102, 1165–1169 (1970)PubMedGoogle Scholar
  48. 48.
    Peters, N., Hales, C. N.: Plasma insulin concentrations after myocardial infarction. Lancet1965 I, 1144–1145Google Scholar
  49. 49.
    Nikkila, E. A., Miettinen, T. A., Vesenne, M. R., Pelkonen, R.: Plasma insulin in coronary heart disease. Lancet1965 II, 508–511Google Scholar
  50. 50.
    Tzagournis, M., Chiles, R., Ryan, J. M., Skillman, T. G.: Interrelationships of hyperinsulinism and hypertriglyceridemia in young patients in coronary heart disease. Circulation38, 1156–1163 (1968)PubMedGoogle Scholar
  51. 51.
    Malherbe, C., de Gasparo, M., Berthet, P., de Hertogh, R., Hoet, J. J.: The pattern of plasma insulin response to glucose in patients with a previous myocardial infarction — the respective effects of age and disease. Eur. J. Clin. Invest.1, 265–270 (1970)Google Scholar
  52. 52.
    Gertler, M. M., Leetma, H. E., Saluste, E., Rosenberger, J. L., Guthrie, R. G.: Ischemic heart disease. Insulin, carbohydrate and lipid interrelationships. Circulation46, 103–111 (1972)PubMedGoogle Scholar
  53. 53.
    Sorge, F., Schwartkopff, W., Neuhaus, G. U.: Insulin response to oral glucose in patients with a previous myocardial infarction and in patients with peripheral vascular disease. Diabetes25, 586–594 (1976)PubMedGoogle Scholar
  54. 54.
    Welborn, T. A., Breckenridge, A., Rubenstein, A. H., Dollery, C. T., Fraser, T. R.: Serum-insulin in essential hypertension and in peripheral vascular disease. Lancet1966 I, 1336–1337Google Scholar
  55. 55.
    Gertler, M. M., Leetma, H. E., Saluste, E., Covalt, D. A., Rosenberger, J. L.: Covert diabetes mellitus in ischaemic heart and cerebrovascular disease. Geriatrics27, 105–120 (1972)Google Scholar
  56. 56.
    Berchtold, P., Bjorntorp, P., Gustafson, A., Lindholm, B., Tiblin, T., Wilhalmsen, L.: Glucose tolerance, plasma insulin and lipids in relation to adipose tissue cellularity in men after myocardial infarction. Acta Med. Scand.191, 35–41 (1972)PubMedGoogle Scholar
  57. 57.
    Christiansen, I., Deckert, T., Kjerulf, K., Mitgaard, K., Worning, H.: Glucose tolerance, plasma lipids and serum insulin in patients with ischaemic heart disease. Acta Med. Scand.184, 283–287 (1968)PubMedGoogle Scholar
  58. 58.
    Devlin, J. G., Stephenson, N.: Hyperinsulinism and hypoglycaemia following acute myocardial infarction. Metabolism17, 999–1004 (1968)PubMedGoogle Scholar
  59. 59.
    Sloan, J. M., Mackay, J. S., Sheridan, B.: The incidence of plasma insulin, blood sugar and serum lipid abnormalities in patients with atherosclerotic disease. Diabetologia7, 431–433 (1971)PubMedGoogle Scholar
  60. 60.
    Friedman, M., Byers, S. O., Roseman, R. H., Elevitch, F. R.: Coronary-prone individuals (type A behaviour pattern). Some biochemical characteristics. J.A.M.A.212, 1030–1037 (1970)PubMedGoogle Scholar
  61. 61.
    Rubenstein, A. H., Seftel, H. C., Miller, K., Bersohn, I., Wright, A. D.: Metabolic responses to oral glucose in healthy South African white, Indian, and African subjects. Br. Med. J.1969 I, 748–751Google Scholar
  62. 62.
    Logan, R. L., Thomson, M., Riemersma, R. A., Oliver, M. F., Olsson, A. G., Rossner, S., Callmer, E., Walldius, G., Kaijser, L., Carlson, L. A., Lockerbie, L., Lutz, W.: Risk factors for ischaemic heart-disease in normal men aged 40 (Edinburgh-Stockholm study). Lancet1978 I, 949–955Google Scholar
  63. 63.
    Elkeles, R. S., Lowy, C., Wyllie, A. D. H., Young, J. L., Fraser, T. R.: Serum insulin, glucose and lipid levels among mild diabetics in relation to incidence of vascular complications. Lancet1971 I, 880–883Google Scholar
  64. 64.
    Ghilchik, M. W., Morris, A. S.: Insulin response to glucose in patients with peripheral vascular disease, arteritis, and Raynaud's phenomenon. Lancet1971 II, 1229–1231Google Scholar
  65. 65.
    Luft, R., Efendic, S., Cerasi, E.: Prediabetes, diabetes and arteriosclerosis. In: Early phases of coronary heart disease. Larsson, T., Ljungstedt, N. (Eds.), pp. 223–232. Stockholm: Nordiska 1973Google Scholar
  66. 66.
    Duff, G. L., McMillan, G. C.: The effect of alloxan diabetes on experimental atherosclerosis in the rabbit. I. The inhibition of experimental atherosclerosis in alloxan diabetes. II. The effect of alloxan diabetes on the retrogression of experimental cholesterol atherosclerosis. J. Exp. Med.89, 611–630 (1949)Google Scholar
  67. 67.
    McGill, H. C., Holman, R. L.: The influence of alloxan diabetes on cholesterol atheromatosis in the rabbit. Proc. Soc. Exp. Biol. Med.72, 72–75 (1949)PubMedGoogle Scholar
  68. 68.
    Duff, G. L., Brechin, J. H., Finkelstein, W. E.: The effect of alloxan diabetes on experimental cholesterol atherosclerosis in the rabbit. IV The effect of insulin therapy on the inhibition of atherosclerosis in the alloxan-diabetic rabbit. J. Exp. Med.100, 371–380 (1954)PubMedGoogle Scholar
  69. 69.
    Cook, D. L., Mills, L.M., Green, O. M.: The mechanism of alloxan protection in experimental atherosclerosis. J. Exp. Med.99, 119–124(1954)PubMedGoogle Scholar
  70. 70.
    Beveridge, J. M. R., Johnson, S. E.: Studies on diabetic rats: the production of cardiovascular and renal disease in diabetic rats. Br. J. Exp. Pathol.31, 285–293 (1950)PubMedGoogle Scholar
  71. 71.
    Lehner, N. D. M., Clarkson, T. B., Lofland, H. B.: The effect of insulin deficiency, hypothyroidism, and hypertension on atherosclerosis in the squirrel monkey. Exp. Mol. Pathol.15, 230–244 (1971)PubMedGoogle Scholar
  72. 72.
    Kalant, N., Teitelbaum, J. I., Cooperberg, A. A., Harland, W. A.: Dietary atherogenesis in alloxan diabetes. J. Lab. Clin. Med.63, 147–157 (1964)Google Scholar
  73. 73.
    Pierce, F. T.: The relationship of serum lipoproteins to atherosclerosis in the cholesterol-fed alloxanized rabbit. Circulation5, 401–407 (1952)PubMedGoogle Scholar
  74. 74.
    Kalant, N., Harland, W. A.: The effect of an atherogenic diet on normal and alloxan-diabetic rats. Can. Med. Assoc. J.84, 251–254 (1961)PubMedGoogle Scholar
  75. 75.
    Wilson, R. B., Martin, J. M., Hartroft, W. S.: Failure of insulin therapy to prevent cardiovascular lesions in diabetic rats fed an atherogenic diet. Diabetes18, 225–231 (1969)PubMedGoogle Scholar
  76. 76.
    Cruz, A. B., Amatuzio, D. S., Grande, F., Hay, L. J.: Effect of intra-arterial insulin on tissue cholesterol and fatty acids in alloxan-diabetic dogs. Circ. Res.9, 39–43 (1961)PubMedGoogle Scholar
  77. 77.
    Foster, D. W., Siperstein, M. D.: Effect of diabetes on cholesterol and fatty acid synthesis in the rat aorta. Am. J. Physiol.198, 25–28 (1960)PubMedGoogle Scholar
  78. 78.
    Wertheimer, H. E., Bentor, V.: Influence of diabetes on carcohydrate metabolism of aortic tissue. Diabetes11, 422–425 (1962)PubMedGoogle Scholar
  79. 79.
    Mulcahy, P. D., Winegrad, A. I.: Effects of insulin and alloxan diabetes on glucose metabolism in rabbit aortic tissue. Am. J. Physiol.203, 1038–1042 (1962)Google Scholar
  80. 80.
    Urrutia, G., Beavan, D. W., Cahill, G. F.: Metabolism of glucose-U-C14 in rat aorta in vitro. Metabolism11, 530–534 (1962)PubMedGoogle Scholar
  81. 81.
    Mahler, R. F.: Diabetes and arterial lipids. Q. J. Med.34, 484–485 (1965)Google Scholar
  82. 82.
    Gabbay, K. H.: The sorbitol pathway and the complications of diabetes. N. Engl. J. Med.288, 831–836 (1973)PubMedGoogle Scholar
  83. 83.
    Clements, R. S., Jr., Morrison, A. D., Winegrad, A. I.: Polyol pathway in aorta: regulation by hormones. Science166, 1007–1008 (1969)PubMedGoogle Scholar
  84. 84.
    Morrison, A. D., Clements, R. S., Winegrad, A. I.: Effects of elevated glucose concentrations on the metabolism of the aortic wall. J. Clin. Invest.51, 3114–3123 (1972)PubMedGoogle Scholar
  85. 85.
    Whereat, A. E.: Atherosclerosis and metabolic disorder of the arterial wall. Exp. Mol. Pathol.7, 233–247 (1967)PubMedGoogle Scholar
  86. 86.
    Bierman, E. L., Eisenberg, S., Stein, O., Stein, Y.: Very low density lipoprotein ‘remnant’ particles: uptake by aortic smooth muscle cells in culture. Biochim. Biophys. Acta329, 163–169 (1973)PubMedGoogle Scholar
  87. 87.
    Kramsch, D. M., Hollander, W.: The interaction of serum and arterial lipoproteins with elastin of the arterial intima and its role in the lipid accumulation in atherosclerotic plaques. J. Clin. Invest.52, 236–247 (1973)PubMedGoogle Scholar
  88. 88.
    Zilversmit, D. B.: A proposal linking atherogenesis to the interaction of endothelial lipoprotein lipase with triglyceriderich lipoproteins. Circ. Res.33, 633–638 (1973)PubMedGoogle Scholar
  89. 89.
    Ross, R.: The smooth muscle cell. II Growth of smooth muscle in culture and formation of elastic fibres. J. Cell Biol.50, 172–186 (1971)PubMedGoogle Scholar
  90. 90.
    Stout, R. W., Bierman, E. L., Ross, R.: The effect of insulin on the proliferation of cultured primate arterial smooth muscle cells. Circ. Res.36, 319–327 (1975)PubMedGoogle Scholar
  91. 91.
    Ledet, T., Dzoga, K. F., Wissler, R. W.: Growth of rabbit aortic smooth-muscle cells cultured in media containing diabetic and hyperlipemic serum. Diabetes25, 207–215 (1976)PubMedGoogle Scholar
  92. 92.
    Ledet, T.: Growth of rabbit aortic smooth muscle cells in serum from patients with juvenile diabetes. Acta Pathol. Microbiol. Scand. [A]84, 508–516 (1976)Google Scholar
  93. 93.
    Ledet, T.: Growth hormone stimulating the growth of arterial medial cells in vitro. Diabetes25, 1011–1017 (1976)PubMedGoogle Scholar
  94. 94.
    Ross, R., Glomset, J. A., Kariya, B., Harker, L.: A platelet-dependent serum factor that stimulates the proliferation of arterial smooth muscle cells in vitro. Proc. Natl. Acad. Sci. USA71, 1207–1210 (1974)PubMedGoogle Scholar
  95. 95.
    Ross, R., Glomset, J. A.: Atherosclerosis and the smooth muscle cell. Science180, 1332–1339 (1973)PubMedGoogle Scholar
  96. 96.
    Vracko, R., Benditt, E. P.: Manifestations of diabetes mellitus — their possible relationships to an underlying cell defect. Am. J. Pathol.75, 204–222 (1974)PubMedGoogle Scholar
  97. 97.
    Goldstein, S., Littlefield, J. W., Soeldner, J. S.: Diabetes mellitus and aging: diminished plating efficiency of cultured human fibroblasts. Proc. Natl. Acad. Sci. USA64, 155–160 (1969)PubMedGoogle Scholar
  98. 98.
    Martin, G. M., Sprague, C. A., Epstein, C. J.: Replicative life-span of cultivated human cells. Effects of donor's age, tissue and genotype. Lab. Invest.23, 86–92 (1970)PubMedGoogle Scholar
  99. 99.
    Goldstein, S., Moerman, E. J., Soeldner, J. S., Gleason, R. E., Barnett, D. M.: Chronologic and physiologic age affect replicative life-span of fibroblasts from diabetic, prediabetic, and normal donors. Science199, 781–782 (1978)PubMedGoogle Scholar
  100. 100.
    Vracko, R.: Basal lamina layering in diabetes mellitus: evidence for accelerated rate of cell death and cell regeneration. Diabetes23, 94–104 (1974)PubMedGoogle Scholar
  101. 101.
    Stout, R. W.: Insulin stimulation of cholesterol synthesis by arterial tissue. Lancet1969 II, 467–468Google Scholar
  102. 102.
    Stout, R. W.: The effect of insulin on the incorporation of (1-14C) sodium acetate into the lipids of the rat aorta. Diabetologia7, 367–372 (1971)PubMedGoogle Scholar
  103. 103.
    Stout, R. W.: The effect of insulin on the incorporation of D-glucose-U-14C in the lipids of the rat aorta in vivo. Horm. Metab. Res.7, 31–34 (1975)Google Scholar
  104. 104.
    Stout, R. W., Buchanan, K. D., Vallance-Owen, J.: Arterial lipid metabolism in relation to blood glucose and plasma insulin in rats with streptozotocin-induced diabetes. Diabetologia8, 398–401 (1972)PubMedGoogle Scholar
  105. 105.
    Orimo, H., Sakurada, T., Ito, H., Okabe, H., Noma, A., Murakami, M.: Lipid metabolism in aorta of rats with streptozotocin-induced diabetes. Artery1, 335 (1975)Google Scholar
  106. 106.
    Stout, R. W.: Development of vascular lesions in insulintreated animals fed a normal diet. Br. Med. J.1970 III, 685–687Google Scholar
  107. 107.
    Stout, R. W., Buchanan, K. D., Vallance-Owen, J.: The relationship of arterial disease and glucagon metabolism in insulin-treated chickens. Atherosclerosis18, 153–162 (1973)PubMedGoogle Scholar
  108. 108.
    Stout, R. W.: The effect of insulin and glucose on sterol synthesis in cultured rat arterial smooth muscle cells. Atherosclerosis27, 271–278 (1977)PubMedGoogle Scholar
  109. 109.
    Stout, R. W.: Relative insensitivity to glucagon of sterol synthesis in cultured rat aortic smooth muscle cells. Effect of dibutyryl cyclic AMP. Diabetologia15, 323–326 (1978)PubMedGoogle Scholar
  110. 110.
    Chait, A., Bierman, E. L., Albers, J. J.: Regulatory role of insulin in the degradation of low density lipoprotein by cultured human skin fibroblasts. Biochim. Biophys. Acta529, 292–299 (1978)PubMedGoogle Scholar
  111. 111.
    Goldstein, J. L., Brown, M. S.: Lipoprotein receptors, cholesterol metabolism, and atherosclerosis. Arch. Pathol. Lab. Med.99, 181–184 (1975)Google Scholar
  112. 112.
    Stamler, J., Pick, R., Katz, L. N.: Effect of insulin in the induction and regression of atherosclerosis in the chick. Circ. Res.8, 572–576 (1960)PubMedGoogle Scholar
  113. 113.
    Renold, A. E., Genet, A. E., Stauffacher, W., Jeanrenaud, B.: Laboratory animals with spontaneous diabetes and/or obesity: suggested suitability for the study of spontaneous atherosclerosis. Prog. Biochem. Pharmacol.4, 363–369 (1968)Google Scholar
  114. 114.
    Stout, R. W., Vallance-Owen, J.: Insulin and atheroma. Lancet1969 I, 1078–1080Google Scholar
  115. 115.
    Stout, R. W.: The relationship of abnormal circulating insulin levels to atherosclerosis. Atherosclerosis27, 1–13 (1977)PubMedGoogle Scholar
  116. 116.
    Oakley, W. G., Pyke, D. A., Tattersall, R. B., Watkins, P. J.: Long-term diabetes. Q. J. Med. NS43, 145–156 (1974)Google Scholar
  117. 117.
    Bierman, E. L.: Hypertriglyceridemia in early diabetes. Adv. Metab. Disord. [Suppl.2], 67–72 (1973)Google Scholar

Copyright information

© Springer-Verlag 1979

Authors and Affiliations

  • R. W. Stout
    • 1
  1. 1.Department of Geriatric MedicineThe Queen's University of BelfastBelfastNorthern Ireland

Personalised recommendations